Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Lilly sees big sales increase in 2026 despite pricing pressures
Eli Lilly has projected revenue of between $80 billion and $83 billion in 2026, which would be a 25% increase from 2025 sales at the midpoint.
Kevin Dunleavy
Feb 4, 2026 2:55pm
BMS turns focus to new growth drivers as legacy meds decline
Feb 5, 2026 11:45am
Sponsored
Why Innovation Matters in First-Line HER2+ GEA
Feb 2, 2026 8:00am
Novartis CEO eyes 2026 growth despite record patent cliff
Feb 4, 2026 2:30pm
Sponsored
Why human expertise still matters in AI-driven med comms
Feb 2, 2026 8:00am
Top 10 most anticipated drug launches of 2026
Feb 2, 2026 3:00am
More News
US government readies TrumpRx portal rollout
Feb 5, 2026 2:59pm
Fierce Healthcare
Hims & Hers plans to launch $49 copy of Wegovy pill
Feb 5, 2026 1:00pm
Astellas lifts forecast as Vyloy surge counters trial miss
Feb 5, 2026 11:00am
Veradermics locks in $256M IPO, shares spike
Feb 5, 2026 10:01am
